158 results
Page 6 of 8
8-K
EX-10.2
23dk5
24 Nov 20
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-99.1
fvthpujmaxjbix
3 Nov 20
Adial Pharmaceuticals Provides Update on its ONWARD™ Pivotal Phase 3 Trial of AD04 for Treatment of Alcohol Use Disorder
9:54am
8-K
EX-99.1
8kbpa
21 Oct 20
Adial Pharmaceuticals Announces FDA Reactivation of its Investigational New Drug Application for AD04 in Alcohol Use Disorder
12:26pm
8-K
EX-99.1
cdd5h0q
30 Sep 20
Other Events
9:00am
8-K
EX-99.1
jawo1ps67tsafa ckc98
28 Sep 20
Adial Pharmaceuticals Files for Expedited Review of AD04 with the FDA
9:52am
8-K
EX-99.1
owrydfo8zf6yhj
22 Sep 20
Adial Pharmaceuticals and iRemedy Partner to Sell COVID-19 Antibody Test Kits to U.S. Medical Providers and Commence Sales
9:31am
8-K
EX-99.1
j7o6bpqmog1b1z dq
6 Aug 20
Adial Pharmaceuticals Announces Third-Party Sales and Distribution Agreement with Brik for Rapid Result COVID-19 Antibody Test Kits
10:04am
424B3
bs2vie
13 Jul 20
Prospectus supplement
4:46pm
8-K
EX-99.1
gpjkkkkvohtur8zox7dc
11 Jun 20
Adial Pharmaceuticals Announces Approval to Commence Landmark ONWARD™ Pivotal Phase 3 Trial in Poland
11:58am
424B5
anrxocab
10 Jun 20
Prospectus supplement for primary offering
4:14pm
8-K
EX-10.1
ofwyq 7fm2agsm1b
10 Jun 20
Adial Pharmaceuticals Announces Pricing of $5.2 Million Registered Direct Offering Priced At-The-Market
4:05pm
8-K
EX-10.2
8fwoqrjvlot0ft0 ur
10 Jun 20
Adial Pharmaceuticals Announces Pricing of $5.2 Million Registered Direct Offering Priced At-The-Market
4:05pm
8-K
EX-99.1
bifcz22jkjn 6e5
10 Jun 20
Adial Pharmaceuticals Announces Pricing of $5.2 Million Registered Direct Offering Priced At-The-Market
4:05pm
8-K
EX-99.1
6bw1rmfr
8 Jun 20
Adial Pharmaceuticals and BioLab Sciences Enter into Distribution Agreement
9:40am
424B3
v2d7opgl3nb
22 May 20
Prospectus supplement
4:30pm
424B3
8157t7239hxumel4wra
22 May 20
Prospectus supplement
4:28pm